AI powered data denoising for biosensor detection enhancement
Leverage AI and biosensors to improve detection limits by training AI models to denoise signals, enhancing sensitivity beyond conventional methods. This enables high-precision micronutrient detection at low levels.
Overview
Omics Archive presents an innovative solution that integrates AI with biosensors to significantly enhance detection limits for micronutrient analysis. By utilizing protein biosensors capable of binding to various molecules, this technology employs AI to denoise signals, allowing for detection sensitivity that surpasses traditional human and electronic methods. The key advantage lies in the ability to train AI models on edge case results, thus refining the detection process for trace micronutrients.
Technical specifications
Key features:
- Protein Biosensors: Designed to bind with a wide range of molecules, providing a foundational 15% accuracy.
- AI Denoising: Utilizes AI algorithms to analyze and remove noise from biosensor signals, improving detection limits in low-concentration scenarios.
- Iterative Optimization: AI models are iteratively optimized using edge case data to refine detection capabilities.
- Micronutrient Specificity: Development focuses on modifying protein scaffolds to selectively bind specific micronutrients, enhancing detection precision.
Technology readiness level
Currently, the technology is at TRL 3, indicating experimental proof of concept. The next steps include identifying specific micronutrients, optimizing protein binders, and deploying AI models for real-world testing and continual updates.
About Omics Archive
Omics Archive is a biotechnology company that integrates artificial intelligence, blockchain, and synthetic biology to advance sustainable biomanufacturing. The company provides a platform that utilizes federated learning to allow AI developers to train models on proprietary and in-house omics and digital sequence datasets while maintaining data privacy. By leveraging blockchain technology, the platform enables the conversion of omics data and digital sequences into tradable assets, supporting a marketplace for data licensing, generation funding, and trading stakes in datasets.
This integrated approach aims to accelerate data-driven discoveries and innovations in the biotechnology sector. The platform offers services that support the decentralized management of data assets and the operational needs of autonomous biomanufacturing plants. By providing tools for researchers and businesses to navigate microbial omics data, Omics Archive seeks to enhance the velocity and marketability of synthetic biology initiatives, facilitating more efficient research and development cycles for biotech start-ups.
delivered to your inbox.